BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19421648)

  • 21. Efficacy of dalbavancin against methicillin-resistant Staphylococcus aureus in the rat granuloma pouch infection model.
    Jabés D; Candiani G; Romanó G; Brunati C; Riva S; Cavaleri M
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1118-23. PubMed ID: 15047510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and microbiological characteristics of Staphylococcus aureus infections in infectious diseases hospital Iaşi].
    Petrache SM; Miftode E; Leca D; Dorneanu O; Luca V
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(1):192-6. PubMed ID: 21495317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Ribes S; Pachón-Ibáñez ME; Domínguez MA; Fernández R; Tubau F; Ariza J; Gudiol F; Cabellos C
    Eur J Clin Microbiol Infect Dis; 2010 Nov; 29(11):1361-7. PubMed ID: 20680368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Dailey CF; Dileto-Fang CL; Buchanan LV; Oramas-Shirey MP; Batts DH; Ford CW; Gibson JK
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2304-8. PubMed ID: 11451689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
    Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ
    J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of teicoplanin and linezolid therapies in patients with methicillin-resistant Staphylococcus aureus pneumonia acquired from respiratory intensive care unit].
    Taşbakan MS; Korkmaz Ekren P; Pullukçu H; Başarık B; Susur A; Aydemir S; Başoğlu OK; Bacakoğlu F
    Mikrobiyol Bul; 2010 Jul; 44(3):357-66. PubMed ID: 21063985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of cerebral abscess due to methicillin-resistant Staphylococcus aureus which is treated with linezolid + rifampin combination].
    Sipahi OR; Cağıran I; Yurtseven T; Işıkgöz Taşbakan M; Arda B; Tünger A; Ulusoy S
    Mikrobiyol Bul; 2010 Oct; 44(4):651-5. PubMed ID: 21063978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linezolid compared with vancomycin for the prevention of methicillin-resistant Staphylococcus aureus or Staphylococcus epidermidis vascular graft infection in rats: A randomized, controlled, experimental study.
    Sacar S; Sacar M; Kaleli I; Toprak S; Cevahir N; Teke Z; Asan A; Sahin B; Baltalarli A; Turgut H
    Curr Ther Res Clin Exp; 2007 Jan; 68(1):23-31. PubMed ID: 24678116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of vancomycin-intermediate Staphylcoccus aureus endocarditis with linezolid.
    Leung KT; Tong MK; Siu YP; Lam CS; Ng HL; Lee HK
    Scand J Infect Dis; 2004; 36(6-7):483-5. PubMed ID: 15307573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of linezolid versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus discitis: a controlled animal model.
    Conaughty JM; Chen J; Martinez OV; Chiappetta G; Brookfield KF; Eismont FJ
    Spine (Phila Pa 1976); 2006 Oct; 31(22):E830-2. PubMed ID: 17047530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The cutting-edge of medicine anti-MRSA agents; how to select and how to use].
    Niki Y
    Nihon Naika Gakkai Zasshi; 2012 Apr; 101(4):1085-91. PubMed ID: 22730740
    [No Abstract]   [Full Text] [Related]  

  • 32. Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron.
    Ghiselli R; Giacometti A; Goffi L; Cirioni O; Mocchegiani F; Orlando F; Paggi AM; Petrelli E; Scalise G; Saba V
    J Surg Res; 2001 Aug; 99(2):316-20. PubMed ID: 11469904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
    Hilliard JJ; Fernandez J; Melton J; Macielag MJ; Goldschmidt R; Bush K; Abbanat D
    Antimicrob Agents Chemother; 2009 May; 53(5):2028-33. PubMed ID: 19273686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model].
    Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Riva A; Saba V; Scalise G
    Infez Med; 2001 Mar; 9(1):13-8. PubMed ID: 12082344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B
    Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implant stability in the treatment of MRSA bone implant infections with linezolid versus vancomycin in a rabbit model.
    Schroeder K; Simank HG; Lorenz H; Swoboda S; Geiss HK; Helbig L
    J Orthop Res; 2012 Feb; 30(2):190-5. PubMed ID: 21815204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The levels of cytokines in rats following the use of prophylactic agents in vascular graft infection.
    Gul M; Yasim A; Aral M
    Bratisl Lek Listy; 2010; 111(6):316-20. PubMed ID: 20635674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model.
    Jacqueline C; Batard E; Perez L; Boutoille D; Hamel A; Caillon J; Kergueris MF; Potel G; Bugnon D
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3706-11. PubMed ID: 12435665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis.
    Kalil AC; Murthy MH; Hermsen ED; Neto FK; Sun J; Rupp ME
    Crit Care Med; 2010 Sep; 38(9):1802-8. PubMed ID: 20639754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.